Rachael Johnson
Psychiatric/Mental Health · Carbondale, ILNPI 1306317383
Payments from drug & device makers
Across 272 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$678
- AbbVie$608
- Teva Pharmaceuticals USA, Inc.$523
- Alkermes, Inc.$509
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$439
- Neurocrine Biosciences, Inc.$426
- plus $2K from 12 others
What the payments were for
- Food & beverage$4,93099%
- Education$681%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 40 | $678 |
| AbbVie | 39 | $608 |
| Teva Pharmaceuticals USA, Inc. | 34 | $523 |
| Alkermes, Inc. | 28 | $509 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $439 |
| Neurocrine Biosciences, Inc. | 30 | $426 |
| E.r. Squibb & Sons, L.L.C. | 7 | $372 |
| Johnson & Johnson | 17 | $351 |
| Lundbeck LLC | 17 | $345 |
| Vanda Pharmaceuticals Inc. | 8 | $187 |
| Axsome Therapeutics, Inc. | 7 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $159 |
| Supernus Pharmaceuticals, Inc. | 5 | $85 |
| Avanir Pharmaceuticals, Inc. | 3 | $44 |
| Indivior Inc. | 2 | $31 |
| GSK | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,998 in reported general payments places this provider in the 90th percentile of 922 psychiatric/mental health providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 14 | $119,644 |
| RexultiBrexpiprazole | 41 | $63,806 |
| VraylarCariprazine Hcl | 36 | $50,949 |
| Lurasidone Hcl | 141 | $41,153 |
| Invega SustennaPaliperidone Palmitate | 14 | $34,910 |
| TrintellixVortioxetine Hydrobromide | 17 | $8,009 |
| Quetiapine Fumarate | 273 | $6,854 |
| Ziprasidone Hcl | 65 | $6,694 |
| Aripiprazole | 161 | $6,422 |
| Vilazodone Hcl | 47 | $5,835 |
| VyvanseLisdexamfetamine Dimesylate | 15 | $5,796 |
| Paliperidone ErPaliperidone | 34 | $4,754 |
| Lisdexamfetamine Dimesylate | 19 | $4,259 |
| Clozapine | 48 | $4,129 |
| Trazodone Hcl | 297 | $3,962 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $426 | $119,64414 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $678 | $63,80641 claims |
| AbbVieVraylar | $608 | $50,94936 claims |
| Johnson & JohnsonInvega Sustenna | $351 | $34,91014 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $159 | $13,80532 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 922 psychiatric/mental health providers in Illinois.
Other psychiatric/mental health in Carbondale
- Linda DoddCarbondale$6K
- Erin PetrusicChicago$517K
- Maurice BrownleeChicago$162K
- Melissa VitaleChicago$151K
- Alan AmbergChicago$119K
- Jaime MendozaMaryville$111K
- Jennifer TheryMaryville$83K
- Carole Weddington HuntGranite City$67K
- Jessica WhelanBloomington$55K
- Lynn LochnerKankakee$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.